Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC-S: N-Acetylcysteine for Thrombolysis in Acute Ischemic Stroke
NCT04920448Phase 2Terminated
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in ischemic stroke, sponsored by CHU Caen Normandie. Started Jun 2021; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04920448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04920448.